Cybersecurity Concerns with Medtronic Insulin Pumps

Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has been used in the treatment of diabetes for decades. Devices have evolved with technological advancements; some insulin pumps now feature Bluetooth connectivity and complementary smartphone applications while the use of AI technology is slowly being integrated. Modern insulin pumps are both more patient and physician-friendly […]

First “Follow-On” Insulin Now Available in the United States

One year after the US FDA granted approval to the first “follow-on” insulin, the long-acting insulin glargine product has been officially launched in the United States. Approved as a follow-on and not a biosimilar, the long-acting insulin glargine has already been made available in Europe, and is available as a 100 Units/mL strength in 3-mL […]

Insulin Degludec/Liraglutide 1 Step Closer to US FDA Approval

An FDA advisory committee has voted unanimously in favor of approval of the combination type 2 diabetes treatment insulin degludec/liraglutide. The panel also agreed that the combination treatment would at least be appropriate for patients who had previously used an insulin analogue or GLP-1 agonist, but no other consensus was reached regarding which patient types […]